Capital World Investors’s Definium Therapeutics DFTX Stock Holding History

Capital World Investors’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252M	Buy	+5,367,723	New	+$133M	0.03%	300

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Capital World Investors's DFTX Position: Q2 2026 in Review

Capital World Investors opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 5,367,723 shares worth $252M. The stake represents 0.03% of the portfolio and ranks #300 among its holdings.

188 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Capital World Investors held 5,367,723 shares of Definium Therapeutics worth $252M as of Q2 2026.
Definium Therapeutics was a new Capital World Investors position in Q2 2026.
Definium Therapeutics made up 0.03% of Capital World Investors's portfolio in Q2 2026, its #300 holding.
188 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.